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Introduction: The prevalence of obesity is rising progressively, even among elderly patients. Many
studies investigated about safety and efﬁcacy of bariatric surgery among aged obese patients. The
objective of this review is to assess the beneﬁts relative to risks of weight loss that may be obtained by
performing two common bariatric procedures in obese elderly patient. Materials and methods: We
retrospectively evaluated 10 morbid obese patients older than 60 years reaching 5 years of follow up who
respectively underwent Laparoscopic Sleeve Gastrectomy (LSG) or Laparoscopic Adjustable Gastric
Banding (LAGB). Eventual changes in comorbidities, weight loss, EWL% were investigated. Results:
Although LSG patients required a longer postoperative hospital stay than LAGB patients (p < 0.001), both
procedures have shown to be safe and equally effective for weight loss achievement in elderly patients.
Whereas all patients showed comorbidities resolution, no signiﬁcant difference in weight loss between
LAGB group and LSG group was found at 1 year (EWL% p ¼ 0.87; BMI p ¼ 0.32), 3 years (EWL% p ¼ 0.62;
BMI p ¼ 0.79) and 5 years (EWL% p ¼ 0.52; BMI p ¼ 0.46) of follow up. Conclusions: Bariatric surgery is
safe and effective to reach obesity related comorbidities resolution among elderly obese patients. Both
LAGB and LSG determine a weight loss lesser than observed in a standard bariatric population. In this
study LSG is signiﬁcantly less cost effective than LAGB. Larger studies with longer follow up are however
needed to evaluate the real impact of bariatric surgery on weight loss, resolution of comorbidities and
improvement of quality of life in elderly obese patients.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Obesity is deﬁned as an unhealthy excess of body fat, which
increases the risk of medical illness and premature mortality [1].
The epidemic explosion of morbid obesity problem has led an
increasing interest in the possibility of use of bariatric surgery. Intrectomy; LAGB, laparoscopic
rate; BMI, body mass index;
bolism; DVT, deep venous
d haemoglobin; FPG, fasting
stay.
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including further increase in morbid obesity [1,2].
In Italy, according to national data between 1991 and 2010, the
prevalence of obesity among the elderly has increased from 7.5% to
16% [3]. Obesity causes serious medical complications, which lead
to considerable morbidity, impaired quality of life, and premature
death. Furthermore the prevalence of many of the medical com-
plications associated with obesity such as diabetes and hyperten-
sion increases with age [4,5].
The Italian Society for Bariatric and Metabolic Surgery (SICOB),
recommends bariatric surgery in obese elderly patients, in any case
younger than 70 years old, emphasizing the need for greater
attention to the assessment of costebeneﬁt ratio. In fact, patients
over sixty years are supposed to have more postoperative compli-
cations, a slight decrease of expected weight loss and a lower
compliance to the dietary regimen than younger patients.
In this study we report one single centre experience in bariatric
procedures with patients aged over 60 years who underwent.
Table 2
Results at 1, 3 and 5 years follow-up.
Pz BMI
1 y
Weight
1 y
EWL% 1
y
BMI 3
y
Weight
3 y
EWL% 3
y
BMI 5
y
Weight
5 y
EWL% 5
y
1 44.4 115 kg 10% 38.6 100 kg 23.1% 36.6 95 kg 26.9%
2 34.6 82 kg 13.7% 26.6 63 kg 33.7% 27 64 kg 32.6%
3 38.6 100 kg 18% 34.7 90 kg 26.2% 28.5 74 kg 39.3%
4 37.2 100 kg 9.1% 28.3 76 kg 30.9% 27.3 75 kg 31.8%
5 40 101 kg 15.8% 35.6 90 kg 25% 28.5 72 kg 40%
6 38.2 121 kg 13.6% 26.8 85 kg 39.3% 25.6 81 kg 42.1%
7 46.3 100 kg 11.5% 42.6 92 kg 18.6% e e e
8 37.4 91 kg 17.3% 33.3 81 kg 26.4% 32.1 78 kg 29.1%
9 42.9 114 kg 15.5% 35.8 95 kg 29.6% 30.1 80 kg 40.7%
10 40.3 107 kg 16.4% 36.9 98 kg 23.4% 29.4 78 kg 39.1%
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Gastric Banding (LAGB) with ﬁve years of follow up.
2. Patients and methods
Starting from 2005, 520 morbid obese patients have been
operated on in our centre [6]. A total of 10 elderly patients aged>60
years old who underwent bariatric surgery in this period at our
institution, and reaching at least ﬁve years of follow up, was
retrospectively examined in this study. Patients were grouped as
follows:
Group A, 6 patients who underwent LAGB and Group B, 4 pa-
tients who underwent LSG, see Table 1 for preoperative details.
We interviewed and examined all the patients at our institution
to obtain accurate pre- and postoperative medical proﬁles. Group A
(6 LAGB patients) had a mean age of 65.8 years, a mean preoper-
ative Body Mass Index (BMI) of 45.4 and presented hyper-
cholesterolaemia in two cases. Group B (4 LSG patients) had amean
age of 66.2 years, a mean preoperative BMI of 48.2, and comor-
bidities such as Type 2 Diabetes Mellitus (T2DM) (3 cases), hyper-
tension (3 cases), and hypercholesterolaemia (2 cases).
All LAGB and LSG were performed by laparoscopy. In particular
LAGB procedures were performed using the pars ﬂaccida approach
[6] while LSG was performed following a previously described
technique [7,8]. According to SICOB guidelines for prevention of
pulmonary embolism (PE) and deep venous thrombosis (DVT), all
patients were administered continuous, intravenous, low-dose
heparin infusion and intraoperative pneumatic leg compression
for prophylaxis.
A structured follow-up that included periodical visits was pro-
vided for all patients. Controls were scheduled every three months
during the ﬁrst postoperative year and every six months thereafter.
During visits surgeons performed all necessary adjustments on
gastric banding, while nutritional counselling was provided as well.
Quality of life (QOL) was assessed by bariatric psychologist by
using three factors: physical function, work, and emotional func-
tion/depression. These questionnaires were administered to all
patients 2 weeks before surgery and at the last date of follow-up
after surgery.
Both the diagnosis and resolution of T2DM were deﬁned ac-
cording to the American Diabetes Association (ADA) guidelines [9].
Glycosylated haemoglobin (HbA1c), fasting plasma glucose (FPG),
and need for medications to control blood sugar, were investigated.
Resolution of hypertension was deﬁned as the discontinuation
of antihypertensive medications as determined by the patient
physician.
Resolution of hypercholesterolaemia was deﬁned as the
discontinuation of lipid lowering agents as determined by the pa-
tient physician.
Results for both groups were evaluated at one, three and ﬁve
years following surgery, by comparing BMI, expressed as kg/m2,Table 1
Preoperative parameters.
Patients Age Preop. BMI Preop weight H
1 66 50 130 kg N
2 65 40 95 kg N
3 67 47 122 kg N
4 65 41 110 kg N
5 68 47.6 120 kg N
6 66 44 140 kg Y
7 65 52 113 kg N
8 65 45 110 kg N
9 66 51 135 kg Y
10 67 48 128 kg YEWL% and comorbidities resolution, with the aim to determine
which procedure between LAGB and LSG could be more effective
and safe in elderly patients. Statistical analysis was performed with
SPSS version 14.0 (SPSS©, Chicago, IL, USA) and signiﬁcance was
assigned for p values <0.05. The Student-t test to compare BMI and
EWL% results from both group was used.
3. Results
No surgical conversion from laparoscopic to open surgery was
needed. There were no deaths, perioperative or postoperative
complications. The postoperative hospital length of stay (LOS) was
2.1 ± 0.4 days for LAGB and 7 ± 1 days for LSG (p < 0.001). Nine
patients (90%) reached ﬁve years of follow up.
In group A (LAGB) we found amean EWL of 14.2% at 1 year and a
mean BMI of 39; mean EWL was of 33.5% at 3 years with a mean
BMI of 33.5; at 5 years themean EWLwas 34.6% with amean BMI of
28.7. One patient was lost at follow up four years following surgery.
In group B (LSG) we found an average EWL of 13.9% at 1 year
with a mean BMI of 41.4; EWL was of 28.8% at 3 years, with a mean
BMI of 34.5. At 5 years themean EWLwas 37.2% with a mean BMI of
30.4 (Table 2).
Our analysis demonstrate that no signiﬁcant difference in
weight loss between LAGB group and LSG group was found at 1
year (EWL% p ¼ 0.87; BMI p ¼ 0.32), 3 years (EWL% p ¼ 0.62; BMI
p ¼ 0.79) and 5 years (EWL% p ¼ 0.52; BMI p ¼ 0.46) of follow up.
Also comorbidities resolution and QOL were evaluated at ﬁve
years of follow-up. In both groups complete resolution of all
comorbidities (100%) considered in this study was found.
Quality-of-life measurements improved almost equally after
both procedures with better although not signiﬁcant results
reached by patients who underwent LSG.
4. Discussion
Bariatric surgery is currently indicated for patients with morbid
obesity and most guidelines suggest to include patients with a BMIypertension Diabetes HyperChol Intervention
o Yes Yes LSG
o No Yes LAGB
o No No LAGB
o No No LAGB
o No No LAGB
es Yes No LSG
o No Yes LAGB
o No No LAGB
es No Yes LSG
es Yes No LSG
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cardiorespiratory disease, T2DM, sleep apnoea, and severe osteo-
arthritis, which are expected to improve by surgically induced
weight loss [5].
While age limitations between 18 and 50 stated by the NIH
Consensus Conferences in 1991 were widened over time to age 60
[5,10,11], Dorman et al. [12] showed that patients age 65 or older
undergoing bariatric surgery in the USA increased from the year
2005e2009. In this report, endorsed by the American College of
Surgeons National Surgical Quality Improvement Program, the
outcomes of 48,378 adults with a BMI greater than or equal to
35 kg/m2 who underwent bariatric surgery between 2005 and
2009were evaluated. During this time, the number of patients aged
65 and older seeking bariatric surgery increased from 1.5% to 4.8%.
To date, SICOB [13], in a recent position statement, extends
bariatric surgery indications to elderly patients aged below 70.
Although several reports suggest that rates of perioperative
morbidity and mortality might be higher in older patients [14], the
improvement in intraoperative surgical management and the
optimization of perioperative care, have led to excellent results in
bariatric elderly patients. If older patients have more pre- and post-
operative comorbidities and lose less weight than younger patients,
conversely weight loss and improvement in comorbidities are
clinically signiﬁcant [15,16]. Often the complication rate is in fact
low and related to underlying diseases and not to the operative
technique or procedure itself [17].
Furthermore, following bariatric surgery elderly patients lose a
signiﬁcant amount of weight and this loss is associated with an
improvement in obesity-related comorbidities and an overall
reduction in medication requirements [16].
Willkomm et al. [18] found an apparently higher operative risk
proﬁle in those over age 65 (n ¼ 100) than in younger patients
(n ¼ 1374), with higher rates of sleep apnoea, diabetes, and hy-
pertension. However, the operative outcomes were similar in the
two groups in terms of operative time, LOS, and 30-day readmission
rates. The authors concluded that patients over age 65 had excel-
lent outcomes compared with younger patients, suggesting that
older age is not a risk factor for complications or death with bar-
iatric surgery. In his study Silecchia et al. [19] comparing two
groups of patients who underwent LAGB, demonstrated no signif-
icant differences in terms of postoperative morbidity and comor-
bidity resolution between patients younger or older than 55 years,
while Quebbemann et al. [20] evaluated short term result on
elderly patients after laparoscopic gastric bypass and LAGB,
concluding that bariatric surgery can be performed with acceptable
safety, excellent weight loss, resolution of comorbidities, and sig-
niﬁcant improvement in quality of life in patients older than 65
years. Again Taylor et al. [21] evaluated 40 patients with a mean age
of 65.8 years (range 60e72) and preoperative mean BMI of 42.2
(range 33e54) who underwent LAGB from February 2000 to
September 2005. Mean EWL at 2 years was 54% with a comorbidity
improvement reported in 80% of patients.
Finally Soto et al. [22] and van Rutte et al. [23] report laparo-
scopic sleeve gastrectomy to be an effective and safe procedure for
morbidly obese patients aged 60 and older. It can be performed
with similar results comparing elderly group to younger patients.
Our results although similar in terms of perioperative safety, and
comorbidities resolution, seem to be less encouraging, especially
evaluating ﬁve years of follow up, in terms of weight loss. In group
A (LAGB) in fact a mean EWL of 14.2% at 1 year, of 33.5% at 3 years
and of 34.6% at ﬁve years was found, whereas similar results were
present in Group B (LSG) patients, with an EWL of 13.9%, 28.8% and
37.2% at 1, 3 and 5 years respectively. Furthermore those ﬁndings
appear poorer than results previously reported, in a standard bar-
iatric population, by our group [6].LSG, in our study, seems to be however less cost-effective than
LAGB. If we in fact consider the similar results offered by both LAGB
and LSG in terms of weight loss and comorbidity resolution,
conversely we have to compare them with the signiﬁcant longer
hospital LOS requested for LSG. In this light we may conclude that
probably LAGB should be preferred in elderly bariatric patients.
Furthermore LSG has a safety proﬁle lower than LAGB [24], and
might expose these patients to complications difﬁcult to be
managed [25]. Although presenting 5 years of follow up, this study
has the major limitation of evaluating a sample group too small to
deﬁne any signiﬁcant difference between elderly patients who
underwent LAGB or LSG.
Nevertheless, according to our data, wemay conclude that LAGB
and LSG are two valid bariatric options in terms of perioperative
safety and comorbidity resolution, despite an unsatisfactory weight
loss in the long term in comparison with a standard bariatric
population. They are able to induce a documented improvement in
quality of life for morbidly obese geriatric patients. Larger studies
with longer follow up are however needed.Ethical approval
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